TABLE 4-5 Average Number of Adverse Effects from Not Receiving Research Inputs, Academic Respondents by Research Goal and for Pathways and Industry Respondents

 

Random Sample

Research Goal

Pathways

Industry

Drug Discovery

Basic Research

Other

CTLA4

EGF

NF-kB

Academic Supplier

Delay >1 month

0.68

0.98

0.69

0.33

0.83

1.2

2.85

0.78

Change Research Approach

0.56

0.89

0.54

0.3

0.45

0.7

2.24

0.68

Abandon

0.22

0.07

0.24

0.21

0.27

0.2

0.62

0.39

Make In-house

0.67

0.88

0.65

0.59

0.93

1.2

2.29

1.01

Industry Supplier

Delay >1 month

0.4

0.75

0.39

0.18

1.02

1.1

0.87

0.35

Change Research Approach

0.46

0.66

0.42

0.56

0.68

0.7

1.66

0.49

Abandon

0.27

0.08

0.3

0.26

0.58

0.9

0.28

0.32

Make In-house

0.31

0.44

0.28

0.47

0.69

0.8

0.71

0.33

Respondents

242

24

195

23

21

24

26

62

 

SOURCE: Walsh et al., 2005.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement